Publications by authors named "Michael Campoli"

Claim this Profile
D
Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery.
Ryan B Thorpe, Kyle R Covington, Hillary G Caruso, Ann P Quick, Olga Zolochevska, Michael Campoli

J Am Acad Dermatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Amanda J Tschetter, Michael R Campoli, John A Zitelli, David G Brodland

J Am Acad Dermatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma.
Michael Campoli, David G Brodland, John Zitelli

J Am Acad Dermatol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?
Michael Campoli, James E Fitzpatrick, Whitney High, Soldano Ferrone

J Am Acad Dermatol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition.
Michael Campoli, Soldano Ferrone

Semin Immunopathol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and clinical relevance of chondroitin sulfate proteoglycan 4.
Michael Campoli, Soldano Ferrone, Xinhui Wang

Adv Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.
Michael Campoli, Robert Ferris, Soldano Ferrone, Xinhui Wang

Clin Cancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
Angelica Facoetti, Rosanna Nano, Paola Zelini, Patrizia Morbini, Eugenio Benericetti, Michael Campoli

Clin Cancer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of tumor evasion.
Michael Campoli, Soldano Ferrone, Arnold H Zea, Paulo C Rodriguez, Augusto C Ochoa

Cancer Treat Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance.
Michael R Campoli, Chien-Chung Chang, Toshiro Kageshita, Xinhui Wang, James B McCarthy

Crit Rev Immunol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions.
Chien-Chung Chang, Michael Campoli, Soldano Ferrone

Adv Cancer Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA antigen changes in malignant tumors of mammary epithelial origin: molecular mechanisms and clinical implications.
Michael Campoli, Chien-Chung Chang, Sharon A Oldford, Allison D Edgecombe, Sheila Drover

Breast Dis· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.
Xinhui Wang, Michael Campoli, Hyun Suk Cho, Takeshi Ogino, Nobuyuki Bandoh

J Immunol Methods· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
Chien-Chung Chang, Michael Campoli, Nicholas P Restifo, Xinhui Wang, Soldano Ferrone

J Immunol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms.
Chien-Chung Chang, Michael Campoli, Wei Luo, Wanzhou Zhao, Kurt S Zaenker

Ann N Y Acad Sci· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Xinhui Wang, Michael Campoli, Eric Ko, Wei Luo, Soldano Ferrone

J Immunol Methods· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?
Chien-Chung Chang, Michael Campoli, Soldano Ferrone

Curr Opin Immunol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?
Michael Campoli, Soldano Ferrone

Expert Rev Vaccines· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA class I defects in malignant lesions: what have we learned?
Chien-Chung Chang, Michael Campoli, Soldano Ferrone

Keio J Med· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA class I antigen loss, tumor immune escape and immune selection.
Michael Campoli, Chien-Chung Chang, Soldano Ferrone

Vaccine· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis